Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?
The COVID-19 pandemic is associated with a global health crisis and the greatest challenge for scientists and doctors. The virus causes severe acute respiratory syndrome with an outcome that is fatal in more vulnerable populations. Due to the need to find an efficient treatment in a short time, ther...
Saved in:
Main Authors: | Beata Franczyk (Author), Jacek Rysz (Author), Jarosław Miłoński (Author), Tomasz Konecki (Author), Magdalena Rysz-Górzyńska (Author), Anna Gluba-Brzózka (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases
by: Jacek Rysz, et al.
Published: (2020) -
Are Nutraceuticals Beneficial in Chronic Kidney Disease?
by: Jacek Rysz, et al.
Published: (2021) -
Arterial Hypertension-Oxidative Stress and Inflammation
by: Julia Krzemińska, et al.
Published: (2022) -
The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
by: Klaudia Kowalska, et al.
Published: (2022) -
Empagliflozin-A New Chance for Patients with Chronic Heart Failure
by: Klaudia Kowalska, et al.
Published: (2021)